Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Program death 1 (PD1) haplotyping in patients with breast carcinoma.

Molecular biology reports - 1 Aug 2011

Haghshenas Mohammad Reza, Naeimi Sirous, Talei Abdolrasoul, Ghaderi Abbas, Erfani Nasrollah

Abstract excerpt

Located on chromosome 2q37.3, the programmed death 1 (PD1) gene encodes for PD-1 (also known as CD279), a negative co-stimulator in the immune system. PD-1 renders potent inhibitory effects on T and B lymphocytes as well as monocyte responses. Expression of PD-1 ligands by tumor cells has been reported to contribute in immune system evasion. We aimed, in current study, to investigate the association of two single...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Apoptosis Regulatory Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Case-Control Studies

Share to Gene Frequency

Share to Haplotypes

Share to Polymorphism, Single Nucleotide

Share to Programmed Cell Death 1 Receptor

Source

Identifiers

PMID: 21113674
DOI: 10.1007/s11033-010-0542-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Program death 1 (PD1) haplotyping in patients with breast carcinoma.PMID 21113674Read ↗

PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China.Semantic proximity Read ↗

PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese Women: A Hospital-Based Observational Study.Semantic proximity Read ↗

Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women.Semantic proximity Read ↗

Relationship of Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Polymorphisms with Overall Cancer Susceptibility: An Updated Meta-Analysis of 28 Studies with 60 612 Subjects.Semantic proximity Read ↗

Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome DataSemantic proximity Read ↗

Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma.Semantic proximity Read ↗

Associations of PD-1 and PD-L1 gene polymorphisms with cancer risk: a meta-analysis based on 50 studies.Semantic proximity Read ↗

Correlations of PD-1/PD-L1 Gene Polymorphisms With Susceptibility and Prognosis in Non-Hodgkin Lymphoma in Iranian PopulationSemantic proximity Read ↗

Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies.Semantic proximity Read ↗

Gene code CD274/PD-L1 : from molecular basis toward cancer immunotherapySemantic proximity Read ↗

Evaluation of the Association between Programmed Cell Death-1 Gene Polymorphisms and Hepatocellular Carcinoma Susceptibility in Turkish Subjects. A Pilot Study.Semantic proximity Read ↗

Association of programmed death‐1 gene polymorphisms with the risk of basal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.